Discovery of quinazolines as a novel structural class of potent inhibitors of NF-kappa B activation (Q44271884)

1 December 2017

title

Discovery of quinazolines as a novel structural class of potent inhibitors of NF-kappa B activation (English)

1 reference

1 December 2017

0 references

Masanori Tobe

1 reference

1 December 2017

Yoshiaki Isobe

1 reference

1 December 2017

Hideyuki Tomizawa

1 reference

1 December 2017

Takahiro Nagasaki

1 reference

1 December 2017

Hirotada Takahashi

1 reference

1 December 2017

Tominaga Fukazawa

1 reference

1 December 2017

Hideya Hayashi

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

Bioorganic & Medicinal Chemistry

1 December 2017

published in

1 reference

1 December 2017

1 reference

1 December 2017

1 reference

1 December 2017

page(s)

383-391

1 reference

The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900440-6

7 January 2021

Bacterial superantigens--mechanism of T cell activation by the superantigens and their role in the pathogenesis of infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900440-6

7 January 2021

The role of T-cell costimulatory activation pathways in transplant rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900440-6

7 January 2021

The impact of immunosuppressive drugs on the analysis of T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900440-6

7 January 2021

T lymphocytes in asthma: bronchial versus peripheral responses

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900440-6

7 January 2021

The role of co-stimulation in airway inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900440-6

7 January 2021

Which T cells cause psoriasis?

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900440-6

7 January 2021

Novel immunotherapies for psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900440-6

7 January 2021

Transcriptional regulation by extracellular signals: mechanisms and specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900440-6

7 January 2021

Signal transduction from the cell surface to the nucleus through the phosphorylation of transcription factors

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900440-6

7 January 2021

Function and activation of NF-kappa B in the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900440-6

7 January 2021

Cytokines in clinical and experimental transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900440-6

7 January 2021

NF-kappa B: ten years after

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900440-6

7 January 2021

The role of nuclear factor-kappa B in cytokine gene regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900440-6

7 January 2021

Signal transduction through NF-kappa B.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900440-6

7 January 2021

The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900440-6

7 January 2021

I kappa B-beta regulates the persistent response in a biphasic activation of NF-kappa B

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900440-6

7 January 2021

Structure, regulation and function of NF-kappa B

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900440-6

7 January 2021

New targets for anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900440-6

7 January 2021

Inhibition of TNF-alpha-induced NF-kappaB activation and IL-8 release in A549 cells with the proteasome inhibitor MG-132.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900440-6

7 January 2021

Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900440-6

7 January 2021

Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900440-6

7 January 2021

The anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-kappaB by directly targeting p65

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900440-6

7 January 2021

Inhibition of transcription factor NF-kappaB by sesquiterpene lactones: a proposed molecular mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900440-6

7 January 2021

The effect of a T cell-specific NF-kappa B inhibitor on in vitro cytokine production and collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900440-6

7 January 2021

Synthesis of NF-kappaB activation inhibitors derived from epoxyquinomicin C

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900440-6

7 January 2021

The mechanism of the inflammatory effect of carrageenin

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900440-6

7 January 2021

Local administration of transcription factor decoy oligonucleotides to nuclear factor-kappaB prevents carrageenin-induced inflammation in rat hind paw.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900440-6

7 January 2021

Linear benzoadenine. Stretched-out analog of adenine

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900440-6

7 January 2021

10.1016/S0968-0896(02)00440-6

Identifiers

DOI

1 reference

1 December 2017

1 reference